An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosis, 2015

20176 citationsReviewdiamond Open Access

Authors

Swan Sim Yeap · Subang Jaya Medical Centre

Fen Lee Hew · Subang Jaya Medical Centre

Premitha Damodaran · Hospital Kuala Lumpur

Winnie Siew Swee Chee · International Medical University

Joon Kiong Lee · Assunta Hospital

Emily Man Lee Goh · Hospital Kuala Lumpur

Siew Pheng Chan ·

Abstract

In post-menopausal women and men above 50 years, bisphosphonates remain the mainstay of treatment in GIO. In pre-menopausal women and men below 50 years, bisphosphonates are recommended for those with a prevalent fracture or at very high risk only.

Topics & Keywords

Bone health and osteoporosis research Bone Metabolism and Diseases Bone health and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Osteoporosis and Sarcopenia

Volume 3, Issue 1, pp. 1-7

DOI: 10.1016/j.afos.2017.01.001

Field-Weighted Citation Impact: 0.44